Medigene

Medigene Dividend Coverage

Delisted·Jul 2, 2026

Dividend Coverage Ratio of Medigene (MDG1.DE) as of Oct 23, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Medigene is 2026 - . Dividend Coverage Ratio of Medigene was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medigene Stock analysis

What does Medigene do? Medigene AG, based in Planegg, Germany, is a biotechnology company specializing in developing innovative cancer treatment platforms. The company focuses on personalized T cell-based immunotherapies, including TCR-modified T cells for adoptive therapy, dendritic cell vaccines for low tumor burdens, and T-cell-specific monoclonal antibodies. It operates offices in Martinsried, Germany, and in Washington DC and San Diego, USA, with 136 employees. Medigene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medigene stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Medigene since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Medigene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Medigene

All Key Metrics — Medigene